搜索临床试验以:GIC-102(同种异体 NK 细胞)
总计1404个结果
-
GI Cell, Inc.招聘中
-
Seoul National University HospitalGC Biopharma Corp完全的
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)招聘中
-
gicare Pharma Inc.Algorithme Pharma Inc完全的
-
Xuzhou Medical University招聘中
-
Kowa Research Institute, Inc.撤销
-
IRCCS Azienda Ospedaliero-Universitaria di Bologna未知
-
Beijing 302 HospitalShenzhen Third People's Hospital; The first People's Hospital of Zhengzhou招聘中
-
Chongqing Public Health Medical CenterZhejiang Qixin Biotech; Chongqing Sidemu Biotech未知
-
Margaret Gatti-Mays招聘中解剖学 IV 期乳腺癌 AJCC v8 | HER2-阴性乳腺癌美国
-
Fate Therapeutics终止黑色素瘤 | 淋巴瘤 | 肾细胞癌 | 宫颈癌 | 头颈癌 | 肝细胞癌 | 胃癌 | 大肠癌 | 非小细胞肺癌 | 晚期实体瘤 | 小细胞肺癌 | HER2阳性乳腺癌 | 胰腺癌 | 尿路上皮癌 | 默克尔细胞癌 | 微卫星不稳定性 | 鳞状细胞癌 | EGFR阳性实体瘤美国
-
Universidad Nacional de ColombiaFundación Salud de los Andes撤销
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI)终止急性淋巴细胞白血病 | 套细胞淋巴瘤 | 非霍奇金淋巴瘤 | 骨髓增生异常综合症 | 浆细胞骨髓瘤 | 复发性弥漫性大 B 细胞淋巴瘤 | 难治性弥漫性大 B 细胞淋巴瘤 | 最小残留病 | 治疗相关的急性髓性白血病 | 治疗相关性骨髓增生异常综合征 | 造血细胞移植受者 | 复发性血液系统恶性肿瘤 | TP53基因突变 | 难治性成熟 T 细胞和 NK 细胞非霍奇金淋巴瘤 | 复发性成熟 T 细胞和 NK 细胞非霍奇金淋巴瘤 | 缓解期急性髓性白血病 | JAK2基因突变 | 染色体 17p 丢失 | RAS家族基因突变美国
-
Shanghai iCELL Biotechnology Co., Ltd, Shanghai...Hebei Yanda Ludaopei Hospital未知
-
Fondazione Policlinico Universitario Agostino Gemelli...Ministry of Health, Italy终止
-
Hospital Infantil Universitario Niño Jesús, Madrid...SPANISH HEALTH RESEARCH FUND (FIS)终止
-
Joshua M HareNational Heart, Lung, and Blood Institute (NHLBI)完全的
-
Beijing Kejing Biotechnology Co., Ltd.Beijing Kejing Biotechnology Corp.撤销
-
Capricor Inc.National Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health (NIH); Cedars-Sinai...未知
-
Xinxiang medical universityFirst Affiliated Hospital of Xinjiang Medical University完全的
-
Instituto de Investigación Hospital Universitario...招聘中
-
The Second Affiliated Hospital of Fujian Medical...Shanghai iCELL Biotechnology Co., Ltd, Shanghai, China未知
-
Cedars-Sinai Medical CenterCalifornia Institute for Regenerative Medicine (CIRM)完全的